Wave Life Sciences Home
  • About
    • Overview
    • History
    • Leadership
    • Commitment
    • Contact Us
  • Science
    • Overview
    • Platform
    • Collaborations
    • Manufacturing
  • Pipeline
    • Overview
    • Lead programs
    • Clinical trials
  • Careers
    • Overview
    • Working at Wave
    • Opportunities
  • For Patients
  • For the Scientific Community
  • For Investors & Media
  • Contact Us
Wave Life Sciences Home
  • For Patients
  • For the Scientific Community
  • For Investors & Media
  • Wave Life Sciences Twitter
  • Wave Life Sciences LinkedIn
  • Contact Wave Life Sciences
  • Search Wave Life Sciences

    • History
    • Leadership
    • Commitment
    • Contact
    • Platform
    • Collaborations
    • Manufacturing
    • Lead
      Programs
    • Clinical
      trials
    • Working at Wave
    • Opportunities
  • Search Wave Life Sciences

Architects
of transformation

We are a biotechnology company focused on delivering transformational therapies for patients with serious, genetically defined diseases.

Our proprietary chemistry platform enables the precise design, optimization and production of stereopure oligonucleotides: molecules optimized to potentially deliver greater efficacy, safety and tolerability than stereorandom oligonucleotides. Through the eyes of our world-leading scientists, we see the future of medicine.

Explore our science 

Architects
of transformation

We are a biotechnology company focused on delivering transformational therapies for patients with serious, genetically defined diseases.

Our proprietary chemistry platform enables the precise design, optimization and production of stereopure oligonucleotides: molecules optimized to potentially deliver greater efficacy, safety and tolerability than stereorandom oligonucleotides. Through the eyes of our world-leading scientists, we see the future of medicine.

Explore our science

Architects
of transformation

Jan 11, 2021

Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications

Dec 02, 2020

Wave Life Sciences Announces Appointment of Jonathan Rosin as Chief Human Resources Officer

Vast potential patient impact

We are creating a powerful genetic toolbox with the potential to impact many serious conditions for which there are currently few or no treatment options.

Discover our pipeline

Commitment is our bridge to innovation

Our team shares a commitment to deliver on the promise of precision medicine for the many patients and families battling devastating diseases. These include clinical programs for Huntington’s disease, amyotrophic lateral sclerosis and frontotemporal dementia.

Our clinical trials

Opportunities

Diversity of thought is not only welcomed here, it is expected.

Working at Wave

Patient and community hub

Sign up to receive updates about our investigational medicines, clinical trials and company news.

Connect

Opportunities

Diversity of thought is not only welcomed here, it is expected.

Working at Wave

Patient and community hub

Sign up to receive updates about our investigational medicines, clinical trials and company news.

Connect

About

  • History
  • Leadership
  • Commitment
  • Contact Us

Science

  • Platform
  • Collaborations
  • Manufacturing

Pipeline

  • Lead programs
  • Clinical trials

Careers

  • Working at Wave
  • Opportunities
  • For patients/
  • For the scientific community/
  • For investors & media
Wave Life Sciences
  • Privacy Policy
  • Terms of use
  • Contact

© 2021 Wave Life Sciences. All Rights Reserved.

  • Wave Life Sciences Twitter
  • Wave Life Sciences LinkedIn
Wave Life Sciences
  • Privacy Policy
  • Terms of use
  • Contact

© 2021 Wave Life Sciences. All Rights Reserved.

Cancel Continue
Your browser does not support the video tag.